# Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions

> **NCT01102465** · NA · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 25 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** losartan potassium hydrochlorothiazide

## Key facts

- **NCT ID:** NCT01102465
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-03
- **Final completion:** 2005-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01102465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01102465, "Bioequivalency Study of Losartan Potassium/Hydrochlorothiazide 100 mg /25 mg Tablet Under Fed Conditions". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01102465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*